Conclusions
Zequn
These findings demonstrate how obtaining prognostic biomarkers that predict negative outcomes before treatment decision‐making might influence urologists' preference for recommending aggressive therapy in men eligible for active surveillance.
Samuel Carbunaru and Zequn Sun contributed equally to the manuscript as cofirst authors.
